Ravindra N, Dillon LW, Gui G, Smith M, et al. Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone Marrow Transplant 2024 Jan 5. doi: 10.1038/s41409-023-02189.
PMID: 38182672